Search research articles
Contact Us
Filters
Showing results (551-560 of 579) with videos related to
Page
of 58
Sort By:
Nature Communications
|
December 21, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study
Zihao Guo, Yuchen Wei, Guozhang Lin, et al.
Zhonghua Yi Xue Za Zhi
|
August 10, 2007
[A multicenter survey on the diabetic foot and its neuropathy in China]
Shao-da Lin, Chu-jia Lin, Ai-hong Wang, et al.
BMC Medicine
|
March 18, 2026
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study
Zihao Guo, Yuchen Wei, Aimin Yang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
February 9, 2010
[The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population]
Qing-pei Fu, Hui He, Li Li, et al.
Nature
|
November 12, 2025
Florigen activation complex forms via multifaceted assembly in Arabidopsis
He Gao, Na Ding, Yuang Wu, et al.
Nature Communications
|
November 10, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study
Ka Chun Chong, Yuchen Wei, Carlos King Ho Wong, et al.
The Journal of Infection
|
May 28, 2023
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Rita W Y Ng, Ryan K H Sze, Ka Chun Chong, et al.
Emerging Microbes & Infections
|
February 18, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
The Lancet. Rheumatology
|
November 11, 2024
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study
Guozhang Lin, Yuchen Wei, Huwen Wang, et al.
The Lancet Regional Health. Western Pacific
|
May 8, 2025
Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study
Kehang Li, Yuchen Wei, Chi Tim Hung, et al.
Page
of 58
Search research articles
Search
Showing results (551-560 of 579) with videos related to
Sort By:
Page
of 58
Nature Communications
|
December 21, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study
Zihao Guo, Yuchen Wei, Guozhang Lin, et al.
Zhonghua Yi Xue Za Zhi
|
August 10, 2007
[A multicenter survey on the diabetic foot and its neuropathy in China]
Shao-da Lin, Chu-jia Lin, Ai-hong Wang, et al.
BMC Medicine
|
March 18, 2026
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study
Zihao Guo, Yuchen Wei, Aimin Yang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
February 9, 2010
[The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population]
Qing-pei Fu, Hui He, Li Li, et al.
Nature
|
November 12, 2025
Florigen activation complex forms via multifaceted assembly in Arabidopsis
He Gao, Na Ding, Yuang Wu, et al.
Nature Communications
|
November 10, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study
Ka Chun Chong, Yuchen Wei, Carlos King Ho Wong, et al.
The Journal of Infection
|
May 28, 2023
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Rita W Y Ng, Ryan K H Sze, Ka Chun Chong, et al.
Emerging Microbes & Infections
|
February 18, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
The Lancet. Rheumatology
|
November 11, 2024
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study
Guozhang Lin, Yuchen Wei, Huwen Wang, et al.
The Lancet Regional Health. Western Pacific
|
May 8, 2025
Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective study
Kehang Li, Yuchen Wei, Chi Tim Hung, et al.
Page
of 58